IDWeek 2023: Seasonal Flu Vaccine Offers More Protection for Immunocompetent Adults than Immunocompromised Peers, but “Difference not Statistically Significant”
Researchers say findings demonstrate the capacity to use an existing influenza vaccine effectiveness network to study a large immunocompromised population.
Novo Stops Semaglutide Kidney Outcomes Trial Early for Efficacy
The phase 3 semaglutide kidney outcomes trial will be stopped immediately with FLOW read out expected in early 2024, the company said.
In People Living with HIV, Switch from Oral ART to Long-Acting Injectable Significantly Improved Adherence, Persistence
IDWeek 2023: In a large cohort of people living with HIV, those switching from oral ART to long acting CAB+RPV were more than 4x as likely to adhere to the regimen.
Real-World Study Finds Long-Acting Cabotegravir+Rilpivirine Highly Effective in Persons with HIV with Detectable Viral Loads at Treatment Inititiaton
Approved for persons with HIV with undetectable VL, CAB+RPV LA may also be appropriate for those with VL ≥50 copies when the therapy is initiated, according to new findings.
Adolescents Prefer Combination Meningococcal Vaccine to Separate MenACWY and MenB Administration a New Study Finds
IDWeek 2023: Adolescents expressed a preference for a combination vaccine covering serogroups A, B, C, W, Y of invasive meningococcal disease, reported researchers.
IDWeek 2023: Tripledemic Viruses Under the Microscope
COVID-19, influenza, and RSV will be the topics of a different types of sessions examining the history, new diagnostics, prevention, and future treatments during IDWeek 2023.
US Meningococcal Vaccination Coverage Has Increased, but Disparities Persist, According to Data Presented at IDWeek 2023
Findings underscore the persistence of disparities in meningococcal vaccination coverage in the US, particularly for vaccination against serogroup B.
IDWeek 2023 Features Leaders Spanning the Specialty's Expertise
IDWeek 2023: Leading physician scientists will headline plenary sessions and named lectureships on topics ranging from antibiotic stewardship to artificial intelligence.
How to Get Shots into Arms this Year: Patience, Persistence, and Don't Take it Personally
AAFP president-elect Steven Furr, MD, offers 3 thoughts on maximizing opportunities this year to give all necessary vaccines.
Daily Dose: Primary Care Follow-Up and 30-Day Readmission After Emergency Surgery
Your daily dose of the clinical news you may have missed.
IDWeek 2023, October 11-15: Preview of Topics and Presentations
IDWeek 2023: Imagine an intriguing hot topic in infectious disease and you'll find a session or 2 where you can learn more and then choose the next topic, rinse, and repeat.
AAFP President-Elect Welcomes the Simplicity of the Seasonal COVID-19 Vaccine
The monovalent, singe-shot COVID-19 vaccine simplifies what used to be a complicated conversation with patients and stocking the vaccine fridge, too, says Steven Furr, MD.
Daily Dose: Experimental Nasal Spray Found Effective and Safe for Treating Rapid Heartbeat
COVID-19 Monovalent Vaccines: An ACIP Recommendations Quiz
A 2-question quiz on the ACIP's recommendations on the new COVID-19 monovalent vaccines that provide protection from currently circulating strains.
AAFP President-Elect Steven Furr, MD, Talks About Vaccination in Practice vs in Theory
Furr on COVID-19 shot: The expectation that 90% of the US population would take this new vaccine that they'd never heard of was probably not practical.
Moderna Investigational Dual Flu/COVID-19 Vaccine Shows Positive Phase 1/2 Results
The combination was found equally as effective as 2 standard influenza vaccine comparators and as the Moderna Spikevax COVID-19 booster shot.
Daily Dose: Walking More Reduced BP in Sedentary Older Adults with Hypertension
Updated Novavax COVID-19 Vaccine Authorized by FDA to Protect Against Current Variants
The Novavax COVID-19 vaccine is refreshed with 2023-2024 formula targeting the XBB.1.5 strain.
Use of Maintenance Therapy Suboptimal Before Asthma Exacerbations, New Research Finds
Many patients with moderate-to-severe asthma may not be using inhaled corticosteroids along with rescue medications to avoid serious disease exacerbations.
Daily Dose: Biosimilar Liraglutide Found Safe, Effective for Use in Patients with T2D
